Jenny is an associate in our global transactions group in New York. Her practice focuses on corporate and financial transactions, particularly mergers and acquisitions.
back to tab navigation
- Novartis on its pending €2.7 billion acquisition of MorphoSys AG.
- AstraZeneca on its $1.2 billion acquisition of Gracell Biotechnologies Inc.
- Li-Cycle in connection with its adoption of a limited duration shareholder rights plan.
- Blackstone portfolio company, Schenck Process Group, on the sale of its food and performance materials business to Hillenbrand, Inc.
- Molekule Group on its all-stock merger with Aura Smart Air.
- London Stock Exchange Group on its acquisition of AcadiaSoft.
- CarLotz on its sale to Shift Technologies.
- Zymergen on its pending $300 million sale to Ginkgo Bioworks.
back to tab navigation
